text_1: Once-a-day AIDS pill may be OK’d soon
text_2: This article discusses a once-a-day HIV treatment that may be available at some unknown time in the future. The treatment has been submitted to the FDA for approval. While the companies may be genuinely pleased with the studies they have done to demonstrate that the drugs in combination work as well as they do separately, those results still need to be evaluated by the FDA. This is an article on a re-packaging of a combination of medications currently used for the treatment of AIDS. The story fails to discuss issues that such re-formulation may cause that could be of concern to consumers. In several ways the story reads like it came from a drug company news release, although there is no direct evidence of that. The story would have been helped by interviews with independent experts who could address the evidence. There was really no evidence discussed in this story at all.